• Introducing Dr. Russel Lebovitz CEO/Cofounder of Amprion
• Learn about the research and tests for early detection of neurodegenerative diseases such as Lewy Body Dementia (LBD), Alzheimer’s, and Parkinson’s
• Discuss Lewy Body Dementia, its causes, and symptoms
• Understand the differences are between Dementia, LBD, Alzheimer’s, and Parkinson’s
• What is the “SYNTap Test?

Dr. Russell Lebovitz is the co-founder and CEO of biotech diagnostics company Amprion. He worked also as a senior scientist and research physician, and served on the faculty of Baylor College of Medicine in Houston. The research has led to breakthrough testing for Alzheimer’s, Parkinson’s, and neurodegenerative disease.

A champion for brain health drug development, Russ also works closely with the Alzheimer’s Drug Discovery Foundation (ADDF), playing the role of the principal investigator.

Always eager to collaborate on science, Dr. Russ Lebovitz plays an active part in research projects with the Center for Neurologic Study (CNS), the Michael J. Fox Foundation (MJFF), ALS Association (Golden West Chapter), and several other  Lewy Body Dementia

https://amprionme.com/

Brought to you by J.C. Cooley Foundation "Equipping the Youth of Today for the Challenges of Tomorrow".